MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.arcmed.2023.102919

Медицинская библиотека · Archives of medical research · 2023

Efficacy and Safety of Endoscopic Transsphenoidal Resection for Prolactinoma: A Retrospective Multicenter Case-series.

Zandbergen Ingrid Marijke, Huntoon Kristin Michelle, White Timothy G, Bakker Leontine Erica Henriëtte, Verstegen Marco Johanna Theodorus, Ghalib Luma Mudhafar, van Furth Wouter Ralph, Pelsma Iris Catharina Maria, Dehdashti Amir R, Biermasz Nienke Ruurdje, Prevedello Daniel M

Многоцентровое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Endoscopic transsphenoidal surgery (ETSS) for prolactinoma is reserved for dopamine agonist (DA) resistance, intolerance, or apoplexy. High remission (overall 67%, microprolactinoma up to 90%), low recurrence (5-20%) rates highlighted that surgery might be first-line treatment.

AIMS: To report on outcomes of ETSS in a cohort of prolactinomas.

METHODS

Multicenter retrospective cohort of 137 prolactinoma patients (age 38.2 ± 13.7 years; 61.3% female, median follow-up 28.0 [15.0-55.5] months) operated between 2010-2019 with histopathological confirmation.

RESULTS

Median preoperative prolactin levels were 166 (98-837 µg/L; males 996 [159-2145 µg/L] vs. females 129 [84-223 µg/L], p <0.001). 56 (40.9%) microprolactinomas, 69 (50.4%) macroprolactinomas, and 7 (5.1%) giant prolactinomas were included, whereas no adenoma was detected in 5 (3.6%) patients. Males had larger tumors (macroprolactinomas: 38, 71.7%) vs. 31 (36.9%), p <0.001; giant prolactinomas: 7 (13.2%) vs. 0 (0.0%), (p <0.001). Prolactinomas were graded as KNOSP-3 in 15 (11.5%), and KNOSP-4 in 20 (15.3%) patients. Primary indication was DA intolerance (59, 43.1%); males 14 (26.4%) vs. females 45 (53.6%), p = 0.006. Long-term remission (i.e., DA-free prolactin level <1xULN) was achieved in 87 (63.5%) patients, being higher in intended complete resection (69/92 [75.0%]), and lower in males (25 [47.2%] vs. 62 females [73.8%], p = 0.002). Transient DI (n = 29, 21.2%) was the most frequent complication.

CONCLUSIONS

Despite high proportions of macroprolactinoma and KNOSP 3-4, long-term remission rates were 63.5% overall, and 83.3% in microprolactinoma patients. Males had less favorable remission rate compared to females. These findings highlight that ETSS may be a safe and efficacious treatment to manage prolactinoma.

Для цитирования: Zandbergen Ingrid Marijke, Huntoon Kristin Michelle, White Timothy G, Bakker Leontine Erica Henriëtte, Verstegen Marco Johanna Theodorus, Ghalib Luma Mudhafar, van Furth Wouter Ralph, Pelsma Iris Catharina Maria, Dehdashti Amir R, Biermasz Nienke Ruurdje, Prevedello Daniel M. Efficacy and Safety of Endoscopic Transsphenoidal Resection for Prolactinoma: A Retrospective Multicenter Case-series.. Archives of medical research. 2023. DOI: 10.1016/j.arcmed.2023.102919.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.